Skip to main content

Table 1 Socio-demographic and clinical characteristics of patients at the baseline study visit in the enrolled (safety) population (N = 88)

From: A randomised, double-blind study of polyethylene glycol 4000 and lactulose in the treatment of constipation in children

  Lactulose PEG 4000 p
  (N = 44) (N = 44)  
Gender, n (%)    
 Boys 24 (54.6%) 26 (59.1%) 0.83
 Girls 20 (45.5%) 18 (40.9%) 2 test)
Age, years    
 Mean ± SD 1.98 ± 0.52 1.99 ± 0.50 0.83
 Median [range] 2.0 [1–3] 2.0 [1–3] (Student’s t-test)
Duration of chronic constipation (weeks)    
 Mean ± SD 44.4 ± 28.8 43.2 ± 21.8 0.73
 Median [range] 36 [8–116] 40 [10–104] (Wilcoxon test)
Previous treatment for chronic constipation 26 (59.1%) 27 (61.4%) 0.99 (χ2 test)